AI assistant
Sending…
INSMED Inc — Director's Dealing 2013
Mar 22, 2013
30150_dirs_2013-03-22_d8afee2d-da7d-4b64-98a8-bcb5fb699978.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED INC (INSM)
CIK: 0001104506
Period of Report: 2013-03-20
Reporting Person: Drechsler Andrew T (Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-03-20 | Stock Option-Right to Buy | $6.90 | A | 50000 | Acquired | Common Stock (50000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option-Right to Buy | $6.65 | Common Stock (175000) | 175000 | Direct |
Footnotes
F1: These options shall become exercisable with respect to 25% of the shares of common stock subject to this grant on November 7, 2013, the first anniversary of the date of grant, and with respect to an additional 12.5% of the shares of common stock subject to this grant on each sixth month anniversary of November 7, 2013 thereafter through November 7, 2016.
F2: These options shall become exercisable upon the fulfillment of certain performance criteria.
More from INSMED Inc
Regulatory Filings
2026
May 15
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Report Publication Announcement
2026
May 7
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
Apr 7
Annual Report
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 19